ESRRA and prostate cancer: It is noteworthy to mention that prostate cancer has been reported to be driven by ERα, AR, and non-genomic estrogen signaling pathways mediated by orphan receptors like GPR30 and ERRα and, hence, phytoestrogens have been shown to have a beneficial role in prostate cancer (73, 74).